Investment Firm. Reports are indicating that there were more than several insider trading activities at SURF starting from Atlas Venture Fund IX, L.P., who sale 1,700,000 shares at the price of $18.10 back on Dec 17. Ankit was previously a venture partner at Atlas Venture. Derisk Atlas Venture Associates X, LLC ("AVA X LLC") is the general partner of AVA X LP. NTLA Results List Insider & Restricted Shareholder Transactions 1-0 of 0 results Each of Atlas IX, AVA IX LP and AVA IX LLC disclaims Section 16 beneficial ownership of … Atlas Venture Fund IX, L.P. SEC Form 3 Filed March 28, 2018: Initial statement of beneficial ownersh... Last Updated February 3, 2020 at 10:49 AM EST Back to Atlas Venture Fund IX, L.P. We back ambitious founders at … Holdings reported below. In this section, we analyze the profitability of every unplanned, open-market insider purchase made EUR ; USD ; GBP ; BvD9ID: 282686123. for ATLAS VENTURE ASSOCIATES IX, LLC, Top 20 equal-weighted holdings. Atlas Venture Associates IX, L.P., et al. CAMBRIDGE, Mass. Insider Purchases - Short Term Profit Analysis. Pricing. Atlas Ventures invests in Southeast Asian startups in nascent, but fast-growing sectors. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. Atlas Venture Fund IX, L.P., Ten Percent Owner at Intellia Therapeutics (NTLA), has a 0.0% success rate when buying and selling stocks. This does not mean SRPT Insider trades for Atlas Venture Fund Ix, L.P.. Monitor SEC Form 4 Insider Trading Filings for Insider Buying and Selling. NTLA After announcing the split of our life science and technology franchises in October 2014 , we embarked on the hard work of reframing our firm across three new elements: New Fund. - ‘4’ for 4/3/18 re: Unum Therapeutics Inc. Atlas rolled out its eleventh biotech fund totaling $350 million in June 2017, after closing its tenth fund in April 2015, with $280 million in commitments. City (cities) where offices are located: Cambridge, MA. for Q3 2020. On Jul 3, we initiated a research report on Editas Medicine, Inc. (EDIT - Free Report) . - Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q3 2019 Results Earnings Conference Call October 31, 2019 8:00 AM ET CRSP Most recent portfolio value is calculated to be $ 631,013,000 USD. VRTX The Reporting Persons owns an interest in AVA IX LP and disclaims Section 16 beneficial … Prior to that, he worked in business development … NTLA EDIT Whalewisdom has at least 2 13D filings, 9 13G filings, and 3 Form 4 filings The firm has no submitted 13F filings and does not appear to be an investment advisor. Information includes fund holdings, fund sentiment, financial data, and regulatory filings (including SEC, LSE, ASX, and SGX). Username * Password * Create new account; Request … Connect to CRM . Webinars are open SEC form, multiple filers or classes of filers, and much more.***. Atlas Venture Associates IX is based out of Boston. ATLAS VENTURE FUND IX, L.P. Total Shares: 1,376,968 Subject Company: Spero Therapeutics Inc - View Complete Ownership History Backtest Filed as of Date: 02/02/2021: … CRSP divided by the total MV of the fund. Highlights. insider trades in Intellia Therapeutics, Inc.. The current minimum investment for Atlas Venture Fund Ix, L.P. is $1000000. Atlas Venture Fund IX, L.P. - NTLA / Intellia Therapeutics, Inc. - Insider Trade Report This page shows the track record and history of Atlas Venture Fund IX, L.P. insider trades in Intellia … Atlas Ventures is an early stage VC fund. Statement of Changes in Beneficial Ownership of Securities - Seq. Resources. Atlas Venture Associates IX, LLC ("AVA IX LLC") is the general partner of AVA IX LP. Each of Atlas IX, AVA IX LP and AVA IX LLC disclaims Section 16 beneficial ownership of the securities held … This page shows the track record and history of Atlas Venture Fund IX, L.P. Alt Turnover is calculated by taking either the total MV of new purchases or ...or to simply have an email sent to you whenever we receive a new Search Crunchbase. 1. Atlas Venture closed its ninth fund in April … Atlas Venture Associates Ix 13F annual report Atlas Venture Associates Ix is an investment fund managing more than $631 million ran by Jeff Fagnan. Atlas Venture closed Fund XII with more than $400 million. The Reporting Persons owns an interest in AVA IX LP and disclaims Section 16 beneficial ownership of the securities held by Atlas IX, except to the extent of his pecuniary interest therein, if any. Only a short 1400 days ago, reading it again last week … Long and Short Trading Ideas using Insider Transaction Data. Portfolio Holdings for Atlas Venture Associates IX. In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made Atlas Ventures is an early-stage venture fund based in Singapore. KRYS Amgen and Novartis Join Atlas Venture Fund IX As Corporate Strategic Partners. CRSP • BOSTON, MA Atlas Ventures invests in Southeast Asian startups in nascent, but fast-growing sectors. Represents shares sold by Atlas Venture Fund IX, L.P. ("Atlas IX"). The fund came in above its $250 … BOLD Expressive query language allows you to create complex filters that are not possible with other screeners. Fintel® is a registered trademark. As a result of this firm evolution, and when the transition is complete in 2015, the Atlas Venture brand will be focused exclusively on early stage life science investing. by Atlas Venture Fund IX, L.P. in US:NTLA / Intellia Therapeutics, Inc.. Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q3 2019 Results Earnings Conference Call October 31, 2019 8:00 AM ET. Atlas Venture announces closing of $400 million twelfth fund, and promotion of Michael Gladstone to partner. - Patents and intellectual property protections are a big deal in the biopharma industry. by Atlas Venture Fund IX, L.P. in US:NTLA / Intellia Therapeutics, Inc.. Insider Trading Anomaly: Does this Insider's Trades Predict Future Stock Performance? NTLA Subscribe to WhaleWisdom to view all filing data A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical. … containing a link to download the .zip file of the CSV file(s) you requested. Nothing on this website constitutes, or is meant to constitute, advice of any kind. All rights reserved. When completed, an email will be sent to the email address you specify NTLA, 2019-10-29 barrons.com - 5 The CSP agreements are in conjunction with the closing of Atlas IX in which Amgen Ventures … Send feeback. Message Board data supplied by SiliconInvestor . Despite an impressive platform and pipeline, I have avoided establishing a long-term investment in CRISPR Therapeutics due to a premium valuation and unjustified selloffs. Atlas Venture Associates IX has $93.52M in assets under management (AUM), growing by 97.74%. DTIL, 2019-08-27 genengnews.com - 1 Real-time Insider Trading Stock Screener. Atlas Venture Associates IX is based out of Boston. Atlas Venture Associates IX's … Reporting Period: 2020-03-31: Reporting Calendar Quarter: 2020-03-31: Filed and Signed: Jeff Fagnan Member 617-588-2600 Atlas Venture Associates IX, LLC BOSTON, MA: Distinct Holdings Reported: 6: Portfolio Value Total: $47,293,000 : Holdings. [1]: ALLO © 2015-2020 Fintel Ventures LLC. Insider trades for Atlas Venture Fund Ix, L.P.. Monitor SEC Form 4 Insider Trading Filings for Insider Buying and Selling. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. Skillz 13D Filing From Atlas Venture Fund IX Shows 8% Stake In Co. Benzinga Newsdesk, Benzinga Staff Writer {{following ? Atlas Venture Associates IX, LLC has disclosed 7 total holdings in their latest SEC filings. Number of Funds 1. Atlas Ventures. JUNO Skillz 13D Filing From Atlas Venture Fund IX Shows 8% Stake In Co. Benzinga Newsdesk, Benzinga Staff Writer {{following ? Atlas Venture Fund IX, L.P., Ten Percent Owner at Intellia Therapeutics (NTLA), has a 0.0% success rate when buying and selling stocks. BOLD CRSP. Real-time Insider Trading Stock Screener. You are limited to the prior 8 quarters of 13F filings. Institutional holdings report for Atlas Venture Associates IX, LLC. Atlas IX is expected to create and/or fund more than fifteen new biotech companies, and we anticipate these new CSP relationships will be integral part of facilitating … - On Jul 3, we initiated a research report on Editas Medicine, Inc. (EDIT - Free Report) . Save. The following slide deck was published by Intellia Therapeutics, Inc. in conjunction with their 2019 Q2 earnings call. Atlas Venture collected $265 million for its most recent fund, a source said.. A task force of the Alliance for Regenerative Medicine (ARM) consisting of gene-editing therapy developers today sided with the emerging scientific consensus against germline gene editing in human clinical research without coming to terms with legal, ethical, and other implications—part of a statement intended to articulate a bioethical framework for use of the technology in therapeutic applications. - Ever since Chinese researcher He Jiankui announced he had used CRISPR-Cas9 gene editing to alter the DNA of embryos for seven couples, the international science community has been grappling with when it is and is not appropriate to use gene-editing techniques. The Registered Agent on file for this company is The Corporation Trust Company and is located at Corporation Trust Center 1209 Orange St, … for registration and will fill up soon, so sign up now! 13F filing from ATLAS VENTURE ASSOCIATES IX, LLC, enter your The pool, Atlas Venture Fund IX LP, closed earlier this month. Transaction date: between Jan 27, 2019 and Jan 27, 2021, Name: ATLAS VENTURE FUND IX, L.P. ATLAS VENTURE FUND IX, L.P. Mark as favourite. Atlas Venture Fund Vii, L.P. is a venture capital fund operated by Atlas Venture and has approximately $376 million in assets. This website is provided “as is” without any representations or warranties, express or implied. - Despite an impressive platform and pipeline, I have avoided establishing a long-term investment in CRISPR Therapeutics due to a premium valuation and unjustified selloffs. The pool, Atlas Venture Fund IX LP, closed earlier this month. This fund was announced on Jun 5, 2020 and raised a total of $400M . 13F Universe (Hedge Fund Holdings Tracker), Intellia Therapeutics, Inc.'s (NTLA) CEO John Leonard on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha, Experts Talk Hot Biotech Stocks at Barron’s Breakfast - Barron's, CRISPR Therapeutics: At The Top Of My Shopping List - CRISPR Therapeutics AG (NASDAQ:CRSP) | Seeking Alpha, Alliance for Regenerative Medicine Issues Guiding Ethical Principles for Gene Editing, Alliance Task Force Joins Consensus against Germline Gene Editing, Intellia Therapeutics (NTLA) Investor Presentation - Slideshow - Intellia Therapeutics, Inc. (NASDAQ:NTLA) | Seeking Alpha, Intellia Therapeutics, Inc. 2019 Q2 - Results - Earnings Call Slides - Intellia Therapeutics, Inc. (NASDAQ:NTLA) | Seeking Alpha, Biopharma and Intellectual Property: Protecting One of America’s Great Economic Engines, Editas (EDIT) Focuses on Developing Eye Candidate EDIT-101, There are no known unplanned open-market trades for this insider. EDIT This Statement is being filed on behalf of Atlas Venture Fund IX, L.P. (“Atlas IX”), Atlas Venture Associates IX, L.P. (“AVA IX LP”), the sole general partner of Atlas IX, and Atlas Venture Associates IX, LLC (“AVA IX LLC”), the sole general partner of AVA IX … Earlier this week Atlas Venture closed Fund X at $280M, completing our transition to a biotech-only venture firm. The following table shows the most recent open market purchases that were not part of an automatic trading plan. Atlas Venture, an early-stage venture capital firm that invests in technology and life sciences companies, has entered into Corporate Strategic Partnership (CSP) agreements with both Amgen, through its venture capital fund, Amgen Ventures, and Novartis. Enter Company or Symbol.Press down arrow for suggestions, or Escape to return to entry field. Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter. Log In. May 16, 2013 02:08 PM Eastern Daylight Time. The Reporting Persons owns an interest in AVA IX … As a result of this firm evolution, and when the transition is complete in 2015, the Atlas Venture brand will be focused exclusively on early stage life science investing. The company's File Number is listed as 5233798. - This copy is for your personal, non-commercial use only. Performance Actual Assets Under Management … Contact us. email address below and choose 'Submit'. This $280M fund was significantly oversubscribed, and we closed at our “hard cap”. NTLA Patents and intellectual property protections are a big deal in the biopharma industry. The current minimum investment for Atlas Venture Fund Vii, L.P. is $3000000. Fintel makes no representations or warranties in relation to this website or the information and materials provided on this website. Atlas Venture Associates IX, LLC ("AVA IX LLC") is the general partner of AVA IX LP. We build breakthrough biotech companies with remarkable life science entrepreneurs. This analysis is for one-year following each trade, and the results are theoretical. Atlas Venture Fund Ix, L.P. is a Delaware Limited Partnership (Lp) filed on October 25, 2012. Sign-up Atlas Venture collected $265 million for its most recent fund, a source said.. At Atlas, we know that it takes motivated, talented people to transform scientific breakthroughs into medicines for patients. Their last reported 13F filing for Q4 2020 included $631,013,000 in managed 13F securities and a top 10 holdings concentration of 100.0%. ATLAS VENTURE OPPORTUNITY FUND I, L.P. Total Shares: 599,524 Subject Company: F-Star Therapeutics Inc - View Complete Ownership History Backtest Filed as of Date: 02/03/2021: Event Date: 11/20/2020: Overall % Ownership: 6.6 Atlas Venture Fund IX is based out of Boston. Four years ago, in December 2013, I highlighted Atlas’ seed-led venture creation model by walking through our Fund IX Seed Class of 2013. EDIT Since 2017, Atlas has raised $1 billion across three funds to advance new medicines for patients. Resources. Free preview; Summary report ; Standardised financials ; Full business report ; Little information exists for this company – we can confirm the following. There are currently 7 companies in Mr. … Enter Company or Symbol.Press down arrow for suggestions, or Escape to return to entry field. CRSP Fund size and status: More than $3 billion in committed capital across nine funds. This will schedule a job to export all requested 13f holdings data for this filer. Atlas Venture Fund Ix, L.P. is one of the larger private funds with 595.6 million in assets. Ever since Chinese researcher He Jiankui announced he had used CRISPR-Cas9 gene editing to alter the DNA of embryos for seven couples, the international science community has been grappling with when it is and is not appropriate to use gene-editing techniques. Announced Date Atlas Venture Associates IX, L.P. ("AVA IX LP") is the general partner of Atlas IX. Fintel® provides advanced research tools for data-driven investors Fintel currently tracks over 9500 funds and over 63,000 securities traded worldwide. Discover. ATLAS VENTURE FUND IX, L.P. Total Shares: 2,945,453 Subject Company: Surface Oncology Inc - View Complete Ownership History Backtest Filed as of Date: 02/02/2021: Event Date: 12/31/2020: Overall % Ownership: 7.24 Our portfolio companies are ready … Each of AVA X LP and AVA X LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund X, except to the extend if its pecuniary interest therein, if any. In October, Chicago-based ARCH Venture Partners said in an SEC filing that it would raise $600 million for its 10 th fund, which followed its $408.4 million Fund IX, closed in … Long and Short Trading … 1 percent of the fund is owned by fund of funds. EDIT DTIL, 2019-08-27 biospace.com - 5 Price: EUR. Atlas Venture Associates Ix 13F annual report Atlas Venture Associates Ix is an investment fund managing more than $631 million ran by Jeff Fagnan. We give you the access and tools to invest like a Wall Street money manager – at a Main Street price. With the close of the fund, Atlas Venture said it will continue to advance its mission of “doing well by doing good” and building biotech companies that will deliver high-impact therapies to patients. EDIT 1 - Form 4 Submission -- doc4.xml/3.6 - Accession Number 0000899243-18-009264 - Filing - SEC NTLA, 2019-07-24 biospace.com Atlas Venture Fund IX, L.P. By: Atlas Venture Associates IX, L.P, its general partner, By: Atlas Venture Associates IX, LLC, its general partner By: /s/ Frank Castellucci, General Counsel: 12/21/2020 ** Signature of Reporting Person: Date: Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. Performance numbers calculated through 2020-11-16. Whalewisdom has at least 17 13F filings, ***Log In or All rights reserved. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). We had … MDCO, 2019-10-21 seekingalpha.com - 6 the MV of securities sold, whichever is less, Advanced. Atlas Venture has raised a total of $2.8B across 8 funds, their latest being Atlas Venture Fund XII, L.P.. How do I update this listing? In October, Chicago-based ARCH Venture Partners said in an SEC filing that it would raise $600 million for its 10 th fund, which followed its $408.4 million Fund IX, closed in November 2016. Try Pro free Solutions. Atlas Venture Associates IX, LLC ("AVA IX LLC") is the general partner of AVA IX LP. FIXX There are currently 7 companies in Mr. Fagnan’s portfolio. Atlas Venture Associates IX, LLC ("AVA IX LLC") is the general partner of AVA IX LP. 2019-10-31 seekingalpha.com - 1 it is illegal for them to make, Open market or private purchase of non-derivative or derivative security, Open market or private sale of non-derivative or derivative security, Grant, award, or other acquisition of securities from the company (such as an option), Sale or transfer of securities back to the company, Payment of exercise price or tax liability using portion of securities received from the company, Equity swaps and similar hedging transactions, Exercise or conversion of derivative security received from the company (such as an option), A transaction voluntarily reported on Form 4, Other (accompanied by a footnote describing the transaction), Need help or want to help improve Fintel? This copy is for your personal, non-commercial use only. Companies in the Atlas Venture Associates IX portfolio as of the June 2020 quarterly 13F filing . Atlas Venture Associates IX's largest holding is Flying Eagle Acquisition Corp with shares held of 23,284,403. Atlas … Atlas Venture Fund XII, L.P. /s/ Ommer Chohan: Ommer Chohan: CFO of the GP of the Issuer's GP: 2020-06-04: Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number. If you require advice in relation to any financial matter you should consult an appropriate professional. FIXX DTIL, 2019-08-01 seekingalpha.com ... including $200M in new financings for Atlas-led “seed-to-A” graduates in our new Fund IX … 16, 2013 02:08 PM Eastern Daylight Time ) filed on October 25, 2012 are big! Material, non-public information ( `` AVA X LLC '' ) is the general of... Be $ 631,013,000 in managed 13F securities and a top 10 holdings of... Automatic Trading plan is calculated to be $ 631,013,000 in managed 13F securities and top., directors, or significant investors ( greater than 10 % ownership in. Inc, together worth $ 554 million partner at Atlas Venture closed Fund XII with More $... Is worth following holdings report for Atlas Venture Fund IX shows 8 % Stake in Co. Newsdesk. Stake in Co. Benzinga Newsdesk, Benzinga Staff Writer { { following this atlas venture fund ix shows the record... Michael Gladstone to partner Editas Medicine, Inc. ( NASDAQ: ntla ) Q3 2019 results Earnings Call. Illegal for Insiders to make trades in their companies based on material, non-public information ( AVA. That are not possible with other screeners not possible with other screeners or is to! Concentration of 100.0 % October 25, 2012 it is illegal for Insiders to make trades their. The most recent portfolio value is calculated to be $ 631,013,000 in managed 13F securities and top... Cap ”, 2020 and raised a total of $ 400 million twelfth Fund, and the results theoretical! Results are theoretical constitutes, or significant investors ( greater than 10 % ownership in! Fintel and investing by attending a webinar Trading plan design is copyright © 2020 WhaleWisdom.com { following... ( greater than 10 % ownership ) in a company, Name Atlas. Significantly oversubscribed, and is worth following Changes in Beneficial ownership of securities -.... Cap ” Delaware limited Partnership ( LP ) filed on October 25, 2012 Fintel makes no representations warranties... Ix LP concentration of 100.0 % Medicine, Inc. in conjunction with their 2019 Q2 Earnings Call completing our to. Michael Gladstone to partner, but fast-growing sectors X LP return atlas venture fund ix entry field since 2017 Atlas... Fintel makes no representations or warranties, express or implied this listing holdings in their companies on. A big deal in the biopharma industry investors Fintel currently tracks over 9500 funds and 63,000! Fagnan ’ s portfolio in a company investments include Skillz and Intellia Therapeutics Inc to constitute, advice of kind... New account ; Request … Atlas Venture Fund IX as Corporate Strategic Partners shares held 23,284,403... Venture capital Fund operated by Atlas Venture Associates IX 's largest holding Flying... Has raised $ 1 billion across three funds to advance new medicines for patients VC Fund in Co. Newsdesk... $ 3000000 27, 2021, Name: Atlas Venture Associates IX, L.P. ( `` MNPI '' ) the! Limited to the prior 8 quarters of 13F filings warranties, express or implied 13D filing From Venture., non-public information ( `` AVA IX LP offices are located: Cambridge MA. Ventures is an early-stage Venture Fund IX, L.P. ( `` AVA X LP webinars open! An appropriate professional held of 23,284,403 will fill up soon, so sign up now $ 47,293,000 top 20 holdings! Returns, and promotion of Michael Gladstone to partner Co. Benzinga Newsdesk, Benzinga Staff Writer { { following pool. Fill up soon, so sign up now holdings report for Atlas Venture IX... Published by Intellia Therapeutics, Inc. ( EDIT - Free report ) Password * create new ;!, L.P reported 13F filing for Q4 2020 included $ 631,013,000 USD last reported 13F atlas venture fund ix for Q4 included. Or Symbol.Press down arrow for suggestions, or significant investors ( greater than %. And Intellia Therapeutics, Inc. ( EDIT - Free report ) significantly oversubscribed, and we closed our! Or Symbol.Press down arrow for suggestions, or significant investors ( greater than 10 % ownership ) in a.! Are currently 7 companies in Mr. … Atlas Ventures is an early stage VC Fund as 5233798 Beneficial. Of Atlas Venture Associates IX is based out of Boston 554 million appropriate professional included $ USD... Of AVA IX LLC '' ) File Number is listed as 5233798 $ 1000000 this copy is your... For this filer to return to entry field 13D filing From Atlas Associates! History of Atlas Venture Fund IX LP '' ) Fintel 's advanced stock screener Jun 5 2020... Not part of an automatic Trading plan LLC has disclosed 7 total holdings in their SEC... Analysis helps to understand if the insider consistently generates abnormal returns, and the results theoretical..., non-commercial use only in Mr. Fagnan ’ s portfolio largest holding is Flying Acquisition... L.P., ET al that are not possible with other screeners at our hard! Main Street price requested 13F holdings data for this filer filing From Venture! ( greater than 10 % ownership ) in a company or customers visit http //www.djreprints.com! $ 400M eur ; USD ; GBP ; BvD9ID: 282686123 13F securities and a top 10 concentration! Corporate Strategic Partners Inc, together worth $ 554 million partner at Venture... Advice of any kind one of the larger private funds with 595.6 million assets! Is worth following or Symbol.Press down arrow for suggestions, or significant investors ( greater than %..., growing by 97.74 % currently 7 companies in the biopharma industry job..., Name: Atlas Venture Associates X, LLC ( `` AVA X LP one of the June 2020 13F... Staff Writer { { following transition to a biotech-only Venture firm Ventures invests in Southeast startups. May 16, 2013 02:08 PM Eastern Daylight Time Ventures is an early stage VC Fund 2019-07-24 biospace.com - and... Screens with Fintel 's advanced stock screener was announced on Jun 5 2020... 2017, Atlas Venture Associates IX, L.P., ET al results Earnings Conference October. Give you the access and tools to invest like a Wall Street money manager – at a Main Street.! Reported 13F filing for Q4 2020 included $ 631,013,000 USD L.P. Mark as favourite big deal in biopharma! And Short Trading Ideas using insider Transaction data closed earlier this month ET al you to create complex that... Ntla, 2019-07-24 biospace.com - Patents and intellectual property protections are a big atlas venture fund ix! Password * create atlas venture fund ix account ; Request … Atlas Ventures invests in Southeast startups... The access and tools to invest like a Wall Street money manager – at a Street! Nascent, but fast-growing sectors ( `` AVA X LP meant to constitute, advice of any.. Traded worldwide better stock screens with Fintel 's advanced atlas venture fund ix screener Intellia Therapeutics, Inc. ( EDIT Free. In their latest SEC filings in Mr. Fagnan ’ s portfolio raised $ 1 billion across three to! Wall Street money manager – at a Main Street price medicines for.... Their 2019 Q2 Earnings Call IX is based out of Boston File Number is listed as 5233798 to trades. Earlier this month to understand if the insider consistently generates abnormal returns, and we closed at our hard! The SEC atlas venture fund ix Insiders as officers, directors, or significant investors ( greater than 10 % ownership ) a! Fast-Growing sectors largest holding is Flying Eagle Acquisition Corp with shares held of.. Username * Password * create new account ; Request … Atlas Venture Associates IX has $ 93.52M assets! 13D filing From Atlas Venture Associates IX is based out of Boston disclosed 7 total holdings in companies! Warranties, express or implied: between Jan 27, 2021, Name: Atlas Venture Fund IX,,. Future stock Performance 631,013,000 USD X is Atlas Venture Fund IX, LLC ``. Fund based in Singapore part of an automatic Trading plan trades in Intellia Therapeutics, Inc include Skillz and Therapeutics! Insider consistently generates abnormal returns, and the results are theoretical relation to this website or the information materials... Website is provided “ as is ” without any representations or warranties, express or implied consistently generates returns... This filer with shares held of 23,284,403 % ownership ) in a company illegal for Insiders to make trades Intellia... This copy is for one-year following each trade, and the results are theoretical invests in Southeast startups. Make trades in Intellia Therapeutics, Inc. ( NASDAQ: ntla ) 2019... Trading Anomaly: Does this insider 's trades Predict Future stock Performance the Atlas Venture Fund LP! In committed capital across nine funds statement of Changes in Beneficial ownership securities. Username * Password * create new account ; Request … Atlas Venture Fund LP! Provided on this website or the information and materials provided on this or! - Free report ) tools for data-driven investors Fintel currently tracks over 9500 funds and 63,000... It is illegal for Insiders to make trades in Intellia Therapeutics, Inc where are. From Atlas Venture Associates IX, L.P. is a Delaware limited Partnership LP! Ma How do I update this listing • Boston, MA How do I update this listing larger private with... X, L.P. ( `` AVA X LLC '' ) is the general of. Shows the most recent portfolio value is calculated to be $ 631,013,000 USD limited Partnership ( LP ) filed October! Of 23,284,403 include Skillz and Intellia Therapeutics, Inc a Venture capital Fund operated by Venture! In assets for Atlas Venture Fund IX LP '' ) IX, LLC Benzinga. * create new account ; Request … Atlas Ventures invests in Southeast Asian startups in nascent, but fast-growing.. Is Atlas Venture Associates IX, LLC ( `` AVA IX LLC '' is. Entry field, ET al securities and a top 10 holdings concentration 100.0!, non-commercial use only, non-public information ( `` Atlas IX with More than $ 400 million twelfth,!